The Regeneron Pharmaceuticals company logo is seen on a building at the company’s Westchester campus in Tarrytown, New York September 17, 2020. — Reuters pic
KUALA LUMPUR, Dec 14 — Malaysia’s Health Ministry said on Tuesday it has given conditional approval for the use of the single-dose antibody cocktail Ronapreve, developed by Regeneron and Roche, to treat Covid-19.
It has also approved a request from Merck & Co for a clinical trial import license for its Covid-19 pill Molnupiravir, to be used as part of studies being conducted in Malaysia, the ministry said in a statement. — Reuters